US 7851480
Spiro 2,4-pyrimidinediamine compounds and their uses
granted A61PA61P1/04A61P11/00
Quick answer
US patent 7851480 (Spiro 2,4-pyrimidinediamine compounds and their uses) held by Rigel Pharmaceuticals, Inc. expires Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Rigel Pharmaceuticals, Inc.
- Grant date
- Tue Dec 14 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Dec 09 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P1/04, A61P11/00, A61P17/02, A61P19/02